A detailed history of Ubs Group Ag transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 30,968 shares of CLPT stock, worth $486,507. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,968
Previous 29,047 6.61%
Holding current value
$486,507
Previous $156,000 122.44%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.3 - $13.18 $10,181 - $25,318
1,921 Added 6.61%
30,968 $347,000
Q2 2024

Aug 13, 2024

SELL
$5.25 - $6.73 $120,613 - $154,615
-22,974 Reduced 44.16%
29,047 $156,000
Q1 2024

May 13, 2024

SELL
$6.03 - $7.86 $9,105 - $11,868
-1,510 Reduced 2.82%
52,021 $353,000
Q4 2023

Feb 09, 2024

BUY
$4.46 - $7.07 $62,252 - $98,683
13,958 Added 35.27%
53,531 $363,000
Q3 2023

Nov 09, 2023

SELL
$5.01 - $7.09 $19,979 - $28,274
-3,988 Reduced 9.15%
39,573 $198,000
Q2 2023

Aug 11, 2023

BUY
$6.54 - $10.58 $72,090 - $116,623
11,023 Added 33.88%
43,561 $315,000
Q1 2023

May 12, 2023

BUY
$7.33 - $10.63 $2,015 - $2,923
275 Added 0.85%
32,538 $274,000
Q4 2022

Feb 08, 2023

SELL
$7.7 - $11.21 $38,500 - $56,050
-5,000 Reduced 13.42%
32,263 $273,000
Q3 2022

Nov 10, 2022

BUY
$9.82 - $16.49 $345,241 - $579,738
35,157 Added 1669.37%
37,263 $386,000
Q2 2022

Aug 10, 2022

SELL
$7.09 - $13.65 $24,432 - $47,037
-3,446 Reduced 62.07%
2,106 $27,000
Q1 2022

May 16, 2022

SELL
$7.8 - $11.6 $136,149 - $202,478
-17,455 Reduced 75.87%
5,552 $59,000
Q4 2021

Feb 14, 2022

BUY
$11.08 - $18.86 $29,040 - $49,432
2,621 Added 12.86%
23,007 $258,000
Q3 2021

Nov 15, 2021

BUY
$16.58 - $22.25 $22,051 - $29,592
1,330 Added 6.98%
20,386 $362,000
Q2 2021

Aug 13, 2021

BUY
$17.23 - $22.77 $80,119 - $105,880
4,650 Added 32.28%
19,056 $364,000
Q1 2021

May 12, 2021

BUY
$15.19 - $29.0 $22,860 - $43,645
1,505 Added 11.67%
14,406 $305,000
Q4 2020

Feb 11, 2021

BUY
$5.11 - $15.89 $38,314 - $119,143
7,498 Added 138.77%
12,901 $205,000
Q3 2020

Nov 12, 2020

BUY
$3.19 - $5.89 $17,216 - $31,788
5,397 Added 89950.0%
5,403 $30,000
Q1 2020

May 01, 2020

BUY
$3.33 - $6.14 $19 - $36
6 New
6 $0

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $385M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.